Financial Ratios Fubon Financial Holding Co., Ltd.
Equities
2881
TW0002881000
Life & Health Insurance
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.60 TWD | -1.02% |
|
-0.23% | -8.84% |
| 03-17 | SinoPac Securities Upgrades Fubon Financial Holding to Buy from Neutral; Price Target is NT$96 | MT |
| 03-16 | Fubon Financial Holding Co., Ltd., 2025 Earnings Call, Mar 16, 2026 |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.35 | -0.4 | 1.01 | 0.89 | 1.67 | |||||
Return on Total Capital | 9.54 | -3.19 | 8.67 | 6.83 | 12.45 | |||||
Return On Equity % | 16.73 | 6.15 | 9.36 | 16.93 | 12.32 | |||||
Return on Common Equity | 16.82 | 5.92 | 9.36 | 17.1 | 12.33 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 34.08 | 1.53 | 38.13 | 36.23 | 45.59 | |||||
SG&A Margin | 7.1 | 10.28 | 9.87 | 10.49 | 8.36 | |||||
EBITDA Margin % | 25.55 | -11.07 | 25.62 | 22.65 | 34.94 | |||||
EBITA Margin % | 25.25 | -11.54 | 25.23 | 22.25 | 34.6 | |||||
EBIT Margin % | 25.08 | -11.85 | 24.95 | 21.97 | 34.36 | |||||
Income From Continuing Operations Margin % | 17.32 | 8.46 | 9.26 | 20.15 | 12.47 | |||||
Net Income Margin % | 17.01 | 8.29 | 9.4 | 20.15 | 12.46 | |||||
Net Avail. For Common Margin % | 16.67 | 7.76 | 8.9 | 19.66 | 12.08 | |||||
Normalized Net Income Margin | 11.87 | 6.39 | 6.77 | 14.38 | 8.83 | |||||
Levered Free Cash Flow Margin | 5.76 | 1.32 | -45.19 | -25.93 | 15.35 | |||||
Unlevered Free Cash Flow Margin | 7.61 | 6.78 | -36.05 | -15.61 | 22.93 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.09 | 0.05 | 0.06 | 0.06 | 0.08 | |||||
Fixed Assets Turnover | 12.12 | 7.51 | 8.94 | 8.93 | 10.95 | |||||
Receivables Turnover (Average Receivables) | 359.14 | 391.44 | 478.07 | 741.29 | 724.24 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.77 | 1.82 | 2.12 | 2.72 | 2.55 | |||||
Quick Ratio | 1.58 | 1.54 | 1.84 | 1.96 | 1.74 | |||||
Operating Cash Flow to Current Liabilities | 0.02 | 0.12 | -0.07 | 0.06 | 0.01 | |||||
Days Sales Outstanding (Average Receivables) | 1.02 | 0.93 | 0.76 | 0.49 | 0.5 | |||||
Average Days Payable Outstanding | 7.32 | 15.63 | 21.48 | 53.19 | 53.16 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 53.91 | 93.53 | 73.3 | 64.9 | 75.83 | |||||
Total Debt / Total Capital | 35.03 | 48.33 | 42.3 | 39.36 | 43.13 | |||||
LT Debt/Equity | 30.46 | 50.67 | 41.26 | 40.36 | 51.12 | |||||
Long-Term Debt / Total Capital | 19.79 | 26.18 | 23.81 | 24.48 | 29.07 | |||||
Total Liabilities / Total Assets | 90.63 | 94.58 | 92.65 | 92 | 92.25 | |||||
EBIT / Interest Expense | 8.44 | -1.36 | 1.71 | 1.33 | 2.83 | |||||
EBITDA / Interest Expense | 8.7 | -1.22 | 1.78 | 1.39 | 2.9 | |||||
(EBITDA - Capex) / Interest Expense | 8.59 | -1.27 | 1.74 | 1.36 | 2.84 | |||||
Total Debt / EBITDA | 2.41 | -8.92 | 3.28 | 3.64 | 2.21 | |||||
Net Debt / EBITDA | 1.12 | -3.66 | 1.49 | 1.44 | 0.99 | |||||
Total Debt / (EBITDA - Capex) | 2.45 | -8.55 | 3.36 | 3.74 | 2.26 | |||||
Net Debt / (EBITDA - Capex) | 1.13 | -3.5 | 1.53 | 1.48 | 1.01 | |||||
Tier 1 Capital Ratio % | 11.19 | - | - | - | - | |||||
Total Capital Ratio % | 13.2 | - | - | - | - | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -10.51 | -33.4 | 23.81 | 6.63 | 29.61 | |||||
Gross Profit, 1 Yr. Growth % | 0.42 | -97.02 | 2.51K | 1.32 | 63.09 | |||||
EBITDA, 1 Yr. Growth % | -3.55 | -128.85 | -393.91 | -5.7 | 99.92 | |||||
EBITA, 1 Yr. Growth % | -3.61 | -130.45 | -377.96 | -5.97 | 101.54 | |||||
EBIT, 1 Yr. Growth % | -3.72 | -131.47 | -367.68 | -6.13 | 102.74 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 61.85 | -67.49 | 35.89 | 131.94 | -19.81 | |||||
Net Income, 1 Yr. Growth % | 60.14 | -67.54 | 40.68 | 128.46 | -19.81 | |||||
Normalized Net Income, 1 Yr. Growth % | 58.23 | -64.15 | 27.82 | 126.7 | -20.48 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 60.92 | -70.22 | 42.37 | 135.49 | -20.33 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 16.32 | -0.24 | 8.77 | 4.83 | 6.6 | |||||
Accounts Receivable, 1 Yr. Growth % | -12.32 | -19.07 | -2.65 | -61.07 | 175.93 | |||||
Total Assets, 1 Yr. Growth % | 13.58 | 0.84 | 4.9 | 8.65 | 6.7 | |||||
Common Equity, 1 Yr. Growth % | 24.44 | -41.12 | 43.07 | 18.91 | 3.36 | |||||
Tangible Book Value, 1 Yr. Growth % | 25.48 | -42.7 | 46.07 | 19.71 | 3.4 | |||||
Cash From Operations, 1 Yr. Growth % | -36.21 | 347.59 | -158.45 | -191.19 | -81.39 | |||||
Capital Expenditures, 1 Yr. Growth % | -26.22 | -7.62 | 67.21 | 5.98 | 55.27 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -76.3 | -276.09 | -3.83K | -78.11 | -175.41 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -71.5 | 232.98 | -742.43 | -85.79 | -285.09 | |||||
Dividend Per Share, 1 Yr. Growth % | 28.33 | -55 | 75 | 78.5 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -3 | -22.8 | -9.11 | 14.9 | 17.56 | |||||
Gross Profit, 2 Yr. CAGR % | 21.16 | -82.7 | -3.85 | 414.39 | 28.55 | |||||
EBITDA, 2 Yr. CAGR % | 26.93 | -47.25 | -8.99 | 66.48 | 37.3 | |||||
EBITA, 2 Yr. CAGR % | 27.34 | -45.83 | -9.15 | 61.67 | 37.66 | |||||
EBIT, 2 Yr. CAGR % | 27.55 | -44.96 | -9.33 | 58.52 | 37.96 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 57.21 | -27.46 | -33.54 | 77.53 | 36.38 | |||||
Net Income, 2 Yr. CAGR % | 57.2 | -27.9 | -32.42 | 79.28 | 35.35 | |||||
Normalized Net Income, 2 Yr. CAGR % | 59.03 | -24.69 | -31.37 | 70.23 | 34.27 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 58.62 | -30.78 | -34.89 | 83.1 | 36.97 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.52 | 7.72 | 4.17 | 6.78 | 5.72 | |||||
Accounts Receivable, 2 Yr. CAGR % | -0.23 | -15.76 | -11.24 | -38.44 | 3.64 | |||||
Total Assets, 2 Yr. CAGR % | 10.83 | 7.02 | 2.85 | 6.76 | 7.67 | |||||
Common Equity, 2 Yr. CAGR % | 25.25 | -14.4 | -8.22 | 30.43 | 10.86 | |||||
Tangible Book Value, 2 Yr. CAGR % | 26.48 | -15.21 | -8.52 | 32.23 | 11.26 | |||||
Cash From Operations, 2 Yr. CAGR % | -50.88 | 68.97 | 61.75 | -26.99 | -58.8 | |||||
Capital Expenditures, 2 Yr. CAGR % | 17.08 | -17.44 | 24.29 | 33.12 | 28.28 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -61.83 | -80.95 | 763.62 | 377.81 | -59.02 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -54.22 | -58.88 | 368.57 | 72.21 | -47.99 | |||||
Dividend Per Share, 2 Yr. CAGR % | 38.74 | -24.01 | -11.26 | 76.74 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.05 | -14.43 | -9.58 | -4.14 | 19.61 | |||||
Gross Profit, 3 Yr. CAGR % | 37.22 | -64.76 | -2.45 | -2.16 | 250.76 | |||||
EBITDA, 3 Yr. CAGR % | 57.47 | -22.54 | -7.21 | -7.91 | 76.95 | |||||
EBITA, 3 Yr. CAGR % | 59.11 | -20.96 | -7.34 | -8.1 | 74 | |||||
EBIT, 3 Yr. CAGR % | 59.88 | -20.01 | -7.5 | -8.28 | 72.07 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 45.58 | -7.03 | -10.58 | 0.81 | 36.22 | |||||
Net Income, 3 Yr. CAGR % | 44.68 | -7.08 | -9.91 | 1.42 | 37.11 | |||||
Normalized Net Income, 3 Yr. CAGR % | 40.88 | -3.22 | -9.34 | 2.21 | 32.08 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 44.85 | -9.18 | -11.97 | -0.05 | 38.75 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.85 | 5.52 | 8.07 | 4.39 | 6.72 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.78 | -6.95 | -11.6 | -32.56 | 1.5 | |||||
Total Assets, 3 Yr. CAGR % | 10.82 | 7.4 | 6.31 | 4.75 | 6.74 | |||||
Common Equity, 3 Yr. CAGR % | 27.86 | -2.61 | 1.58 | 0.06 | 20.7 | |||||
Tangible Book Value, 3 Yr. CAGR % | 29.67 | -2.86 | 1.64 | 0.06 | 21.83 | |||||
Cash From Operations, 3 Yr. CAGR % | 117.19 | 2.6 | 18.61 | 33.62 | -53.71 | |||||
Capital Expenditures, 3 Yr. CAGR % | -3.11 | 8.19 | 4.46 | 17.86 | 40.13 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -61.28 | -71.85 | 15.42 | 257.34 | 159.69 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -57.1 | -50.08 | 3.69 | 116.41 | 78.07 | |||||
Dividend Per Share, 3 Yr. CAGR % | 24.4 | -4.67 | 0.35 | 12.02 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.43 | -6.47 | -0.3 | -3.69 | 0.43 | |||||
Gross Profit, 5 Yr. CAGR % | 12.54 | -48.45 | 19.02 | 6.58 | 8.93 | |||||
EBITDA, 5 Yr. CAGR % | 15.33 | -19.22 | 26.46 | 4.7 | 8.53 | |||||
EBITA, 5 Yr. CAGR % | 15.49 | -18.35 | 27.16 | 4.71 | 8.56 | |||||
EBIT, 5 Yr. CAGR % | 15.58 | -17.82 | 27.42 | 4.65 | 8.54 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 24.83 | -2.39 | 6.39 | 20.42 | 5.87 | |||||
Net Income, 5 Yr. CAGR % | 24.45 | -2.81 | 6.7 | 20.86 | 6.02 | |||||
Normalized Net Income, 5 Yr. CAGR % | 24.18 | -0.69 | 5.66 | 21.98 | 6.08 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 23.76 | -4.64 | 5.2 | 20.23 | 5.06 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.66 | 5.62 | 6.95 | 6.02 | 7.12 | |||||
Accounts Receivable, 5 Yr. CAGR % | -1.97 | -6.81 | -7.42 | -21.12 | -5.79 | |||||
Total Assets, 5 Yr. CAGR % | 10.58 | 8.88 | 7.56 | 7.14 | 6.85 | |||||
Common Equity, 5 Yr. CAGR % | 17.28 | 2.64 | 11.98 | 9.46 | 5.2 | |||||
Tangible Book Value, 5 Yr. CAGR % | 18.08 | 2.57 | 12.78 | 9.89 | 5.39 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.72 | 121.57 | 93.04 | -10.46 | -22.3 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.61 | -3.56 | 7.04 | 17.55 | 13.4 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -40.47 | -44.73 | -17.75 | -10.37 | -6.32 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -37.33 | -25.1 | -20.94 | -17.66 | -0.4 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14 | -5.51 | 8.68 | 22.03 | - |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















